Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Rubus fruticosus
Ubiquitous European bramble whose leaves and berries are used for diarrhea, sore throat, and as astringent anti-inflammatory.
Rubus fruticosus (blackberry) is a European bramble whose leaves and berries are traditionally used as an astringent for diarrhea and sore throat, with modern applications as an antioxidant and anti-inflammatory. Its primary active compounds include ellagic acid, tannins, anthocyanins, and quercetin, which contribute to its therapeutic effects. Evidence level C indicates limited clinical studies supporting these uses.
The astringent action is primarily due to hydrolysable tannins (e.g., ellagitannins) that precipitate proteins in mucosal membranes, reducing permeability and secretion. Ellagic acid and quercetin exhibit antioxidant activity via free radical scavenging and inhibition of lipid peroxidation. Anthocyanins and flavonoids modulate inflammatory pathways by inhibiting cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, as well as nuclear factor-kappa B (NF-κB) signaling. These combined actions support antidiarrheal, anti-inflammatory, and wound-healing properties.
Ubiquitous European bramble whose leaves and berries are used for diarrhea, sore throat, and as astringent anti-inflammatory.
Rubus fruticosus (blackberry) is a European bramble whose leaves and berries are traditionally used as an astringent for diarrhea and sore throat, with modern applications as an antioxidant and anti-inflammatory. Its primary active compounds include ellagic acid, tannins, anthocyanins, and quercetin, which contribute to its therapeutic effects. Evidence level C indicates limited clinical studies supporting these uses.
The astringent action is primarily due to hydrolysable tannins (e.g., ellagitannins) that precipitate proteins in mucosal membranes, reducing permeability and secretion. Ellagic acid and quercetin exhibit antioxidant activity via free radical scavenging and inhibition of lipid peroxidation. Anthocyanins and flavonoids modulate inflammatory pathways by inhibiting cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, as well as nuclear factor-kappa B (NF-κB) signaling. These combined actions support antidiarrheal, anti-inflammatory, and wound-healing properties.